Therapeutic proteins (sometimes referred to as biologics or biodrugs) are protein/antibody-based drugs currently being used to treat a variety of diseases, for example autoimmune diseases such as rheumatoid arthritis. With roughly 200 biologics approved for therapeutic applications and over 600 under clinical development, such biotechnology products cover an increased proportion of all therapeutic drugs. This subject will introduce the technology behind this class of drugs, their importance, mode of action and applications. In addition, students will be introduced to cutting edge research methodologies currently underway in this field.
School of Biomedical Sciences
BMS308 Immunology or equivalent
The following table summarises the assessment tasks for the online offering of BMS345 in Session 2 2020. Please note this is a guide only. Assessment tasks are regularly updated and can also differ to suit the mode of study (online or on campus).
The information contained in the CSU Handbook was accurate at the date of publication: May 2021. The University reserves the right to vary the information at any time without notice.